Cardiovascular Research Highlights and EMPA-KIDNEY Trial Analysis - 2022
Yale Cardiovascular Medicine Grand Rounds via YouTube
Overview
Syllabus
Intro
Studies
Methods
Safety
Background
Cohort 1
Cohort 2
Major limitations
Original Follow-up 3.2 Years
Cumulative event rate of cardiovascular death
Non-Cardiovascular Death based on MVD
Key Points
Secondary outcomes
Patient enrollment
Conclusions from the EMPA-KIDNEY trial
Study design
Study outcomes
Pre-defined subgroup analysis
Limitations and strengths
Future directions
Taught by
Yale Cardiovascular Medicine Grand Rounds